All diseases

Disease Atlas / Disease detail

Rett syndrome

An atlas of MECP2-related regression, hand, language and gait changes, and multidisciplinary supportive care.

Rett syndrome · MECP2-related Rett syndrome

MONDO:0010726Public QA completeSource-bound · 4

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · a77e59f0a2a7

Disease class
Rett syndrome is a neurodevelopmental disorder.
Core mechanism
Most cases are associated with pathogenic MECP2 variants.
Genes or cause
Classic disease occurs mainly in females.
Typical features
Regression after early development is a key feature.
Variability
Loss of hand skills and language with stereotypies occurs.
Diagnosis
Gait, breathing, and growth changes can coexist.
Management
Clinical criteria and MECP2 testing establish diagnosis.
Treatment and research
An MECP2 variant alone does not define classic Rett.
Reading evidence
Seizures, scoliosis, and nutrition receive individualized care.
Key caution
Communication, rehabilitation, and devices support participation.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a glance

Rett syndrome is a neurodevelopmental disorder.

Regression after early development is a key feature.

How the disease works

Most cases are associated with pathogenic MECP2 variants.

Classic disease occurs mainly in females.

Why experiences vary

Loss of hand skills and language with stereotypies occurs.

Diagnosis and management

Gait, breathing, and growth changes can coexist.

Treatment status

Clinical criteria and MECP2 testing establish diagnosis.

An MECP2 variant alone does not define classic Rett.

Reading clinical trials

Care goals are adapted across the life course.

Topics for a clinical visit

Regression, seizures, breathing, and nutritional safety require review.

Medical notice

This material is for disease education and is not a personal diagnosis or treatment instruction.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.